Cegedim Customer Information and SK&A presented the latest results from the Physician Connect Oncology Key Opinion Leader (KOL) study at “Key Influencers and their Networks in Oncology,” a forum held June 3 in Chicago.

The latest segment of the study ended in March 2011 and results on breast cancer KOLs were delivered for the first time at the event, which was attended by invitees from pharmaceutical companies, consultancies, and advertising agencies. The results from the Physician Connect study were presented by guest speakers Dr. Alain Herrera, Dr. Peter Harper, and Dr. William Gradishar.

Dr. Alain Herrera headed the Oncology division at Sanofi-Aventis for 10 years before starting his own consultancy. Dr. Peter Harper is a Consultant Physician and Medical Oncologist at Guy’s, King’s & St. Thomas’ Hospital (London). He specializes in research on lung, gynecologic, gastrointestinal, and genitourinary cancers. Dr. William Gradishar is Betsy Bramsen Professor of Breast Oncology, Director, Maggie Daley Center for Women’s Cancer Care, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine.

1: Guest speakers, from left, Dr. Alain Herrera and Dr. Peter Harper meet with Jean-Louis Lompre of Cegedim Customer Information. 2: From left, event moderator Dave Escalante, SK&A; Eric Benillouche, Cegedim Customer Information; Stephane Lomenede, AstraZeneca; and Elodie Godon Minnaert, Cegedim Customer Information. 3: Stephen Murdock and Doug Danison, at left, both from Millennium Pharmaceuticals, meet with Marcus Bergler, Cegedim Customer Information. 4: Oncology product managers from pharmaceutical companies, advertising agencies, and consultancies attended the four-hour symposium.

The Scene highlights significant events in the pharma marketing industry. Companies interested in having event photos published in PM360 should contact editorial@PM360online.com for more details.

Ads